@conference{34b5bba38ee145cba11610ccba17f275,
title = "Neoadjuvant platinum-based chemotherapy (CT) for triple-negative locally advanced breast cancer (LABC): Retrospective analysis of 125 patients",
author = "\{Guardiola Amado\}, \{Victor D\}",
note = "625 Background: Triple-negative breast cancer (TNBC), defined by lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, accounts for 15-20\% of all breast cancers and is associated with poor prognosis. There is no consensus regarding optimal CT for treatment of such patients.; American Society of Clinical Oncology (ASCO) Annual Meeting ; Conference date: 01-01-2014",
year = "2009",
language = "American English",
}